Four-month rifapentine-moxifloxacin tuberculosis (TB) treatment regimen: Considerations for specific groups of people with TB disease

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Four-month rifapentine-moxifloxacin tuberculosis (TB) treatment regimen: Considerations for specific groups of people with TB disease

02/24/2022

[PDF-232.66 KB]

Details You May Also Like

Details:

Description:

This poster important information for health care providers to consider when using the 4-month rifapentine-moxifloxacin regimen as an option to treat people with drug-susceptible pulmonary TB disease.
Document Type:

Poster
CIO:

NCHHSTP
Division:

NCHHSTP_DTBE
Location:

North America
Collection(s):

Historical CDC.gov Content
Main Document Checksum:

[+]

urn:sha256:415ed63b8b31e19f9b40e7a60558c1709cf7c53a259d03f89ae08f9c78aa4e50
Download URL:

https://stacks.cdc.gov/view/cdc/146362/cdc_146362_DS1.pdf
File Type:

No Additional Files

More +

Four-month rifapentine-moxifloxacin tuberculosis (TB) treatment regimen: Considerations for specific groups of people with TB disease

Details:

Supporting Files

You May Also Like